Neurocrine Biosciences, Inc. (NBIX)
154.75
-0.88
(-0.57%)
USD |
NASDAQ |
Dec 11, 16:00
154.66
-0.09
(-0.06%)
After-Hours: 20:00
Neurocrine Biosciences Shareholders Equity (Quarterly): 3.004B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Align Technology, Inc. | 3.957B |
| Hologic, Inc. | 5.048B |
| Masimo Corp. | 810.00M |
| Insulet Corp. | 1.384B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.266B |
| Total Liabilities (Quarterly) | 1.262B |
| Debt to Equity Ratio | 0.1597 |
| Current Ratio | 3.383 |
| Net Debt Paydown Yield | -0.27% |